A Study of Brentuximab Vedotin + Adriamycin, Vinblastine, and Dacarbazine in Pediatric Participants With Advanced Stage Newly Diagnosed Hodgkin Lymphoma
A phase 1/2 trial of Brentuximab vedotin, Doxorubicin, Vinblastine and Dacarbazine in hodgkin lymphoma, run by Takeda, active and no longer recruiting.
Overview
A Study of Brentuximab Vedotin + Adriamycin, Vinblastine, and Dacarbazine in Pediatric Participants With Advanced Stage Newly Diagnosed Hodgkin Lymphoma is a phase 1/2 interventional study registered as NCT02979522 by Takeda, with 59 participants enrolled, started 2017-09-06 and due to reach its primary completion in 2020-05-05. Interventions recorded: Brentuximab vedotin, Doxorubicin, Vinblastine and Dacarbazine. Results have been posted on the registry.
Similar pages
not linked directly; found by shared links- TrialA Study of Brentuximab Vedotin in Combination With Cyclophosphamide, Doxorubicin (Hydroxydaunorubicin), Prednisone (CHP) in Chinese Participants With CD30-Positive (CD30+) Peripheral T-Cell Lymphomas (PTCL)
Shares Brentuximab vedotin, Takeda, Doxorubicin and the tag pipeline.
- TrialPerioperative Durvalumab With Neoadjuvant ddMVAC or Gemcitabine/Cisplatin in Patients With Muscle-invasive Bladder Cancer (NIAGARA-2)
Shares Vinblastine, Doxorubicin and the tag pipeline.
- TrialA Study of TAK-788 in Adults With Non-Small Cell Lung Cancer
Shares Takeda and the tag pipeline.
- TrialA Study of TAK-188 in Adults With Advanced or Spreading Solid Tumors
Shares Takeda and the tag pipeline.
- TrialA Study of TAK-505 in Adults With Solid Tumors
Shares Takeda and the tag pipeline.
- TrialA Study of Gammagard Liquid (Immune Globulin Infusion, 10%) to Prevent Infections in Adults With Multiple Myeloma
Shares Takeda and the tag pipeline.
- TrialA Study of TAK-007 in Adults With Relapsed or Refractory (r/r) B-cell Non-Hodgkin Lymphoma (NHL)
Shares Takeda and the tag pipeline.
- TrialA Study of Rusfertide in Japanese Adults With Polycythemia Vera
Shares Takeda and the tag pipeline.